About
Alex Kadet is a longevity-biotech business development executive publicly associated with Gero, where KrASIA identified him as chief business officer in December 2022 and later 2025 public profiles continued to use that title. Public bios also describe him as a Mentor and Counselor at Longevity Biotech Fellowship and note earlier business-development roles at Longenesis and Open Longevity. His visible profile is centered on partnerships, biotech scaling, and translating AI-driven aging research into commercial collaborations.
Areas of interest
longevitybiotechAI drug discoveryaging biologystrategic partnershipsbusiness developmenttranslational medicine